5-amino-1mq cancer (5mg) 5-Amino-1MQ Australia 10mg NNMT Inhibitor

Brain function: Brain fog, memory problems, cognitive impairment, insomnia, headaches (especially migraine), behavioural changes, learning problems, nominal aphasia Mood: Mood swings, irritability, depression, anxiety, hallucinations, delusions, psychosis Sensory: Peripheral paraesthesia (pins and needles), numbness, neuropathic pains, poor balance, reduced vibration sense or proprioception (joint position sense), tinnitus, ataxia, taste impairment, sometimes myelopathy Constitutional: Fatigue, anaemia (either macrocytic, or normocytic when also iron deficient or associated with thalassaemia minor), other cytopenia, abdominal complaints, malabsorption, failure to thrive, weight loss, diarrhoea, hyperpigmentation, glossitis, (aphthous) stomatitis, infertility, urinary tract infections Motor: Muscle weakness, altered reflexes (increased in degeneration of the spinal cord, reduced when peripheral neuropathy dominates), spasticity, seizures, cardiomyopathy Autonomic: Urinary and/or faecal incontinence, postural hypotension or dizziness, erectile dysfunction Diagnosing B 12 deficiency can be challenging because no single specific measurement exists to reliably diagnose or refute the presence of B 12 deficiency 11 12 26 27 (box 2)

Aging: As we get older, our stomachs naturally make less acid

The classification of a medicine is based on the level of health professional input needed to diagnose and manage the conditions for which the product is used

The amino acid load from arginine HCl can disturb electrolyte balances, for instance, infusions have been observed to provoke hyperkalemia (elevated potassium levels) in patients with compromised liver and kidney function, and serious adverse events (including fatal cardiac arrhythmias) have been reported in such settings

Zhang G